Modelling the anabolic response of bone using a cell population model

Journal of Theoretical Biology

Volumn 307, Issue , 2012, Pages 42-52

  Buenzli, Pascal R ^a   Pivonka, Peter ^a   Gardiner, Bruce S ^a   Smith, David W ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Mathematical model; Osteoblast formation; Proliferation; Prostate cancer metastasis; Wnt signalling

Indexed keywords

DICKKOPF 1 PROTEIN; PARATHYROID HORMONE RELATED PROTEIN; PROSTATE SPECIFIC ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

BONE; CANCER; DISEASE; NUMERICAL MODEL; POPULATION MODELING;

ARTICLE; BONE MASS; BONE METABOLISM; BONE REMODELING; CANCER CELL; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; METASTASIS; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; WNT SIGNALING PATHWAY;

BONE AND BONES; BONE RESORPTION; COMPUTER SIMULATION; HUMANS; MALE; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; ORGAN SIZE; OSTEOBLASTS; OSTEOGENESIS; PARATHYROID HORMONE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; WNT SIGNALING PATHWAY;

EID: 84861385338     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2012.04.019     Document Type: Article

References (50)

1. Aubin J.E. Mesenchymal stem cells and osteoblast differentiation. Principles of Bone Biology 2008, vol. 1:85-107. Academic Press, San Diego, 3 edition.
2. Bonewald L.F., Johnson M.L. Osteocytes, mechanosensing and Wnt signaling. Bone 2008, 42:606.
3. Bubendorf L., Schöpfer A., Wagner U., Sauter G., Moch H., Willi N., Gasser Th.C., Mihatsch M.J. Metastatic pattern of prostate cancer: an autopsy study of 1589 patients. Hum. Pathol. 2000, 31:578-583.
4. Buenzli P.R., Pivonka P., Smith D.W. Spatio-temporal structure of cell distribution in bone multicellular units: a mathematical model. Bone 2011, 48:918-926.
5. Buenzli P.R., Jeon J., Pivonka P., Smith D.W., Cummings P.T. Investigation of bone resorption within a cortical basic multicellular unit using a lattice-based computational model. Bone 2012, 50:378-389.
6. Chirgwin J.M., Guise Th.A. Cancer metastasis to bone. Sci. Med. 2003, 9:140-151.
7. Clarke N.W., Fleisch H.A. The biology of bone metastases from prostate cancer and the role of bisphosphonates. Metastasis of Prostate Cancer 2008, 253-281. Springer. R.J. Ablin, M.D. Mason (Eds.).
8. Cramer S.D., Chen Z., Peehl D.M. Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. J. Urol. 1996, 156:526-531.
9. Di Gregorio, G.B., Yamamoto, M., Ali, A.A., Abe, E., Roberson, P., Manolagas, S.C., Jilka, R.L. Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17Β-estradiol. The Journal of Clinical Investigation 107, 803-812.
10. Fuerer Ch., Nusse R., ten Berge D. EMBO Rep. 2006, 9:134.
11. Gori F., Hofbauer L.C., Dunstan C.R., Spelsberg T.C., Kholsa S., Riggs B.L. The expression of osteoprotegerin and rankligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 2000, 141:4768-4776.
12. Hall Ch.L., Kang S., MacDougald O.A., Keller E.T. The role of wntin prostate cancer bone metastases. J. Cell. Biochem. 2006, 97:661-672.
13. Hall Ch.L., Bafico A., Dai J., Aaronson S.A., Keller E.T. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res. 2006, 65:7554-7560.
14. Henriksen K., Neutzsky-Wulff A.V., Bonewald L.F., Karsdal M.A. Local communication on and within bone controls bone remodeling. Bone 2009, 44:1026-1033.
15. Hodsman A.B., Bauer D.C., Dempster D.W., Dian L., Hanley D.A., Harris S.T., Kendler D.L., McClung M.R., Miller P.D., Olszynski W.P., Orwoll E., Yuen C.K. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr. Rev. 2005, 26:688-703.
16. Iqbal J., Sun L., Zaidi M. Coupling bone degradation to formation. Nat. Med. 2009, 15:729-731.
17. Jaworski Z.F.G., Hooper C. Study of cell kinetics within evolving secondary haversian systems. J. Anat. London 1980, 131:91-102.
18. Ji, B., Genever, P.G., Patton, R.J., Putra, D., Fagan, M.J. A novel mathematical model of bone remodelling cycles for trabecular bone at the cellular level. Biomech. Model. Mechanobiol., in press. http://dx.doi.org/10.1007/s10237-011-0366-3.
19. Jilka R.L. Molecular and cellular mechanisms of the anabolic effect of intermittent pth. Bone 2007, 40:1434-1446.
20. Keller E.T., Zhang J., Cooper C.R., Smith P.C., McCauley L.K., Pienta K.J., Taichman R.S. Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metast. Rev. 2001, 20:333-349.
21. Khosla S., Westendorf J.J., Oursler M.J. Building bone to reverse osteoporosis and repair fractures. J. Clin. Invest. 2008, 118:421-428.
22. Kimmel D.B., Jee W.S.S. Bone cell kinetics during longitudinal bone growth in the rat. Calcif. Tissue Int. 1980, 32:123-133.
23. Komarova S.V., Smith R.J., Dixon S.J., Sims S.M., Wahl L.M. Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling. J. Theor. Biol. 2003, 229:293-309.
24. Krishnan V., Bryant H.U., MacDougald O.A. Regulation of bone mass by wnt signalling. J. Clin. Invest. 2006, 116:1202-1209.
25. Lauffenburger D.A., Linderman J.J. Receptors: Models for Binding, Trafficking, and Signaling 1993, Oxford University Press, New York.
26. Lemaire V., Tobin F.L., Greller L.D., Cho C.R., Suva L.J. Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. J. Theor. Biol. 2004, 229:293-309.
27. Liu F., Malaval L., Aubin J.E. Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation. J. Cell Sci. 2003, 116:1787-1796.
28. Logothetis Ch.J., Lin S.-H. Osteoblasts in prostate cancer metastasis to bone. Nat. Rev. Cancer 2005, 5:21-28.
29. Ma Y.L., Cain R.L., Halladay D.L., Yang X., Zeng Q., Miles R.R., Chandrasekhar S., Martin T.J., Onyia J.E. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 2001, 142:4047-4054.
30. Manolagas S.C., Kousteni K., Jilka R.L. Sex steroids and bone. Recent Prog. Horm. Res. 2002, 57:385-409.
31. Marotti, G., Zambonin Zalone, A., Ledda, M., 1975. Number, size and arrangement of osteoblasts in osteons at different stages of formation. Calcif. Tissue Int. 21, 96-101.
32. Martin T.J. Paracrine regulation of osteoclast formation and activity: milestones in discovery. J. Musculoskelet. Neuronal. Interact. 2004, 4:243-253.
33. Martin R.B., Burr D.B., Sharkey N.A. Skeletal Tissue Mechanics 1998, Springer, New York.
34. McCulloch C.A.G., Melcher A.H. Cell density and cell generation in the periodontal ligament of mice. Am. J. Anat. 1983, 167:43-58.
35. Ogita M., Rached M.T., Dworakowski E., Bilezikian J.P., Kousteni S. Differentiation and proliferation of periosteal osteoblasts progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration. Endocrinology 2008, 149:5713-5723.
36. Parfitt A.M. The physiological and clinical significance of bone histomorphometric data. Bone Histomorphometry: Techniques and Interpretation 1983, 143-223. CRC Press, Boca Raton. R.R. Recker (Ed.).
37. Parfitt A.M. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J. Cell. Biochem. 1994, 55:273-286.
38. Parfitt A.M. Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 2002, 30:5.
39. Pivonka P., Komarova S.V. Mathematical modeling in bone biology: from intracellular signalling to tissue mechanics. Bone 2010, 47:181-189.
40. Pivonka P., Zimak J., Smith D.W., Gardiner B.S., Dunstan C.R., Sims N.A., Martin T.J., Mundy G.R. Model structure and the control of bone remodeling: a theoretical study. Bone 2008, 43:249.
41. Pivonka P., Zimak J., Smith D.W., Gardiner B.S., Dunstan C.R., Sims N.A., Martin T.J., Mundy G.R. Theoretical investigation of the role of the rank-rankl-opgsystem in bone remodeling. J. Theor. Biol. 2010, 262:306-316.
42. Roberts W.E., Mozsary P.G., Klinger E. Nuclear size as a cell-kinetic marker for osteoblast differentiation. Am. J. Anat. 1982, 165:373-384.
43. Roodman G.D. Cell biology of the osteoclast. Exp. Hematol. 1999, 27:1229-1241.
44. Roudier M.P., Morrissey C., True L.D., Higano C.S., Vessella R.L., Ott S.M. Histopathologic assessment of prostate cancer bone 'osteoblastic' metastases. J. Urol. 2008, 180:1154-1160.
45. Ryser M.D., Nigam N., Komarova S.V. Mathematical modeling of spatio-temporal dynamics of a single bone multicellular unit. J. Bone Miner. Res. 2009, 24:860-870.
46. Tang, Y., et al., 2009. TgfΒ1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 15, 757-766.
47. Thomas G.P., Baker S.U., Eisman J.A., Gardiner E.M. Changing rankl/opgmRNA expression in differentiating murine primary osteoblasts. J. Endocrinol. 2001, 170:451-460.
48. Uitterlinden, A.G., et al. 2004. Am. J. Hum. Genet. 75, 1032.
49. van Oers R.F.M., Ruimerman R., Tanck E., Hilbers P.A.J., Huiskes R. A unified theory for osteonal and hemi-osteonal remodeling. Bone 2008, 42:250-259.
50. Wang Y., Pivonka P., Buenzli P.R., Smith D.W. PLoS One 2011, 6(e27494):1-21.